Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study
**Background:** Prescription drug insurance in Canada is constituted of a patchwork of public and private insurance plans. The type of drug insurance may have a negative impact on access to treatment for patients covered by public plans compared with private plans. **Objectives:** In patients with p...
Saved in:
Main Authors: | Laurence Mainville, Hélène Veillette, Paul R. Fortin |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2025-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.127820 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-induced psoriasis
by: Sunil Dogra, et al.
Published: (2019-01-01) -
Patients With Isolated Nail Psoriasis Are at Increased Risk for Asthma Compared to Controls in a Retrospective Cohort Study at a Single Academic Institution
by: Rachel C Hill, et al.
Published: (2025-01-01) -
Reimbursement policies of Swiss health insurances for the surgical treatment of symptomatic breast hypertrophy: a retrospective cohort study
by: Astrid Navarra, et al.
Published: (2025-01-01) -
Psoriasis severity in moderate to severe psoriatic Greek patients routinely treated with systemic treatment: a cross-sectional and retrospective chart review study (CRYSTAL-Greece)
by: Dimitrios Rigopoulos, et al.
Published: (2025-12-01) -
Cross-sectional study of proteomic differences between moderate and severe psoriasis
by: Lingling Wu, et al.
Published: (2025-01-01)